Previous releases of IBM Rational Automation Framework are affected by a vulnerability in Java that may allow remote attackers to influence the availability of the Framework Server.
|Subscribe to My Notifications to be notified of important product support alerts like this.
CVE ID: CVE-2013-0440
Description: Unspecified vulnerability in IBM Java Runtime Environment may allow remote attackers to affect availability via vectors related to JSSE.
The attack does not require local network access nor does it require authentication, but some degree of specialized knowledge and techniques are required. An exploit would not impact the confidentiality of information or the integrity of data, but the availability of the system could be compromised.
CVSS Base Score: 5
CVSS Temporal Score: See http://xforce.iss.net/xforce/xfdb/81799 for the current score
CVSS Environmental Score*: Undefined
CVSS Vector: (AV:N/AC:L/Au:N/C:N/I:N/A:P)
Affected Products and Versions
Rational Automation Framework 18.104.22.168 and earlier on all supported platforms.
For all affected versions of Rational Automation Framework
Upgrade to Rational Automation Framework version 3.0.1 or later.
Workarounds and Mitigations
Get Notified about Future Security Bulletins
26 June 2013: Original copy published
*The CVSS Environment Score is customer environment specific and will ultimately impact the Overall CVSS Score. Customers can evaluate the impact of this vulnerability in their environments by accessing the links in the Reference section of this Security Bulletin.
According to the Forum of Incident Response and Security Teams (FIRST), the Common Vulnerability Scoring System (CVSS) is an "industry open standard designed to convey vulnerability severity and help to determine urgency and priority of response." IBM PROVIDES THE CVSS SCORES "AS IS" WITHOUT WARRANTY OF ANY KIND, INCLUDING THE IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE. CUSTOMERS ARE RESPONSIBLE FOR ASSESSING THE IMPACT OF ANY ACTUAL OR POTENTIAL SECURITY VULNERABILITY.